Duodopa

DRUG3 trials

Sponsors

Poitiers University Hospital, LobSor Pharmaceuticals AB, University Hospital of Ferrara

Conditions

Effect of DrugParkinson DiseaseParkinson's Disease

Phase 1

A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients

CompletedNCT02448914

LobSor Pharmaceuticals ABParkinson's Disease

Start: 2015-05-31End: 2015-07-31Updated: 2016-05-23

Phase 2

Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

CompletedNCT01291537

Poitiers University HospitalParkinson's Disease

Start: 2011-11-30Updated: 2016-10-11

Unknown Phase

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

CompletedNCT06432309

University Hospital of FerraraEffect of Drug, Parkinson Disease

Start: 2022-07-01End: 2024-04-25Updated: 2025-03-03